China Universal Asset Management Company’s Omeros OMER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$144K Sell
15,119
-3,863
-20% -$46K 0.01% 384
2026
Q1
$200K Buy
18,982
+2,429
+15% +$28.6K 0.02% 352
2025
Q4
$284K Sell
16,553
-5,376
-25% -$46.3K 0.02% 314
2025
Q3
$89.9K Buy
21,929
+10,161
+86% +$40.3K 0.01% 395
2025
Q2
$35.3K Buy
11,768
+144
+1% +$717 ﹤0.01% 437
2025
Q1
$95.5K Sell
11,624
-663
-5% -$5.85K 0.01% 359
2024
Q4
$121K Buy
+12,287
New +$84.3K 0.01% 373
2023
Q4
Sell
-1,619
Closed -$4.73K 467
2023
Q3
$4.73K Buy
1,619
+795
+96% +$3.19K ﹤0.01% 397
2023
Q2
$4.48K Sell
824
-26
-3% -$152 ﹤0.01% 381
2023
Q1
$3.95K Buy
850
+213
+33% +$769 ﹤0.01% 391
2022
Q4
$1.44K Buy
637
+49
+8% +$135 ﹤0.01% 386
2022
Q3
$2K Buy
+588
New +$2.73K ﹤0.01% 354

Other funds holding OMER

China Universal Asset Management Company's OMER Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Omeros (OMER) stake by 20% in Q2 2026, selling an estimated $46K and leaving 15,119 shares worth $144K. The position accounts for 0.01% of the portfolio, ranked #384.

China Universal Asset Management Company first reported a position in OMER in Q3 2022 and has held it in 12 quarters since. The position peaked at $284K in Q4 2025. 29 funds tracked by Wall St. Rank hold OMER as of Q2 2026.

  • China Universal Asset Management Company held 15,119 shares of Omeros worth $144K as of Q2 2026.
  • China Universal Asset Management Company sold 3,863 Omeros shares in Q2 2026, an estimated $46K.
  • Omeros made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #384 holding.
  • China Universal Asset Management Company first reported a position in Omeros in Q3 2022 and has held it in 12 quarters since.
  • China Universal Asset Management Company's Omeros position peaked at $284K in Q4 2025.
  • 29 funds tracked by Wall St. Rank held Omeros as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.